Jason Chimon represents both health care and general corporate clients in a variety of corporate transactions, including mergers and acquisitions, private equity, venture capital, and joint ventures, as well as technology-based startups from formation, to capital raises, through exit. He also supports the technology transfer and research operations of clients in negotiating various research and clinical trial agreements.
I represent both buyers and sellers in the purchase and sale of businesses in a wide range of industries including health services, life sciences, and private equity. I also maintain a robust general business law practice, often acting as outside in-house counsel to handle clients’ day-to-day legal needs.
I help my emerging company clients, including those spun-off from academic research institutions, grow their business and raise capital through seed, angel, VC, and private equity financings. This includes advice and negotiation regarding formation, IP licensing, and the other agreements that make up the varied spectrum of issues unique to each start-up client.
I work with academic institutions, pharmaceuticals, CROs, and clinical trial sites to facilitate the conduct of clinical research. I also work closely with academic clients to develop and support their technology transfer programs and these institutions’ various technology-driven transactions. My experience in in-house secondments with both industry and academic clients has given me the hands-on experience needed to best—and most practically—advise my clients.
I see the rise of mobile health technologies and a shift in the way health care is provided. Technology companies will become ever more important players in this space, and hospitals and other institutions will seek new ways to integrate these technologies and partner with businesses in this space, such as through formation of venture funds to invest in these burgeoning technologies.
Boston College, B.A., cum laude
Georgetown University Law Center, J.D.
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe